Maryland Eye Surgeon Ordered to Pay $1.07 Million to Former Patient

The Pennsylvania Supreme Court has ordered a Maryland eye surgeon to pay $1.07 million to a former patient who claimed his vision was damaged by laser eye surgery a decade earlier.

The lawsuit against against Dr. Mark Whitten was filed by former patient David Cantalupo of Pennsylvania after a swift eye laser surgery procedure left him unable to see out of his left eye. According to an attorney representing Mr. Cantalupo the procedure caused the vision in his left eye to be “very blurry, fuzzy” and stated that his client “sees double images.”

The lawsuit accuses Dr. Whitten of failing to warn his patient of the dangers associated with laser eye surgery and failure to collect “informed consent” before performing the procedure.

Dr. Whitten is reportedly Tiger Woods LASIK eye surgeon.

Monovision LASIK

SAN FRANCISCO, CA, January 08, 2011 /24-7PressRelease/ -- Typical of medical progress, new procedures are usually inspired by what is learned from older procedures. Monovision LASIK developed out of a need to improve upon an earlier procedure called conductive keratoplasty, or CK. It's not that CK did not work-it is, in fact, a very successful treatment for presbyopia. But it is not a permanent solution. Over time, as little as two years, CK gradually reverses itself, returning your vision to its original state. Consequently, CK patients face the expense and inconvenience of repeating surgery or finding another solution to gain clear vision within a few years of having CK surgery. Monovision LASIK is one of those solutions.

How Monovision LASIK Corrects Presbyopia

Presbyopia begins to affect just about everyone sometime before age 50. As we age our natural crystalline lenses begin to stiffen and become less flexible. Consequently, the lens' ability change focus quickly is slowed, and the range of focus decreases, particularly affecting near vision. This is when most people begin using reading glasses even if they still see distances well.

Monovision is a technique of creating near vision in the non-dominant eye, which allows reading without glasses. The dominant eye, with good distance vision, is left alone.

Monovision LASIK involves sculpting the cornea of the non-dominant eye to achieve modest nearsightedness.

source: 24-7 Pressrelease

STAAR Surgical's Visian® ICL Surpasses 200,000 Implants

MONROVIA, Calif., Jan. 4, 2011 /PRNewswire/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that the worldwide total number of Visian® ICL implants in patients has exceeded 200,000. Since 1994, STAAR's Implantable Collamer® Lenses (ICLs) have been used in refractive eye surgery as an alternative to LASIK. Manufactured with STAAR's proprietary Collamer material, Visian ICLs provide a safe and effective alternative in the permanent correction of myopia, hyperopia, and in the case of the Toric ICL, astigmatism.

"This milestone demonstrates that STAAR's ICL technology continues to transform the refractive market with increased share in the global surgical market," said Barry G. Caldwell, president and CEO of STAAR Surgical. "During the last half of 2010 we began shipping the new expanded version of the Vision ICL in countries that accept CE Mark Certification. During 2010 Visian ICL sales increased by 15%, while the LASIK segment continues to be challenged. We are most proud of the high level of patient satisfaction delivered by STAAR's technology for placing correction in the posterior segment, which avoids problems experienced with anterior segment phakic lenses. Of the over 200,000 ICLs implanted over the past 17 years, over 14,000 of those have been in eyes for over 10 years.

source: PR Newswire